This Week in PNAS

In a study slated to appear in the early, online edition of the Proceedings of the National Academy of Sciences this week, an Ohio State University-led team assessed the expression of hundreds of microRNAs in ovarian cancer tumors, looking for those with expression profiles that coincided with chemotherapy resistance. Through an array-based analysis of almost 700 microRNAs in tumor samples from 86 women with ovarian cancer, researchers tracked down a 23-miRNA signature for chemoresistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.